Eroglu Cennet-Neslihan, Durmus Ercan, Kiresi Demet
Yuzuncu Yil Universitesi, Dis Hekimligi Fakultesi 65080, Kampus/Van/Turkiye,
Med Oral Patol Oral Cir Bucal. 2014 Nov 1;19(6):e622-7. doi: 10.4317/medoral.19835.
The aim of the present study was to investigate the analgesic and anti-inflammatory effects of dexketoprofen trometamol (DT) and paracetamol on deep acute somatic pain and inflammation in patients undergoing impacted third molar surgery. This study was planned to present benefits that we could obtain with low burden of drug.
Effects of drugs, which were administered preemptively before the procedure, on pain, mouth-opening limitation, and swelling were assessed by visual analogue scale (VAS), magnetic resonance imaging (MRI), and mouth-opening measurement. Following surgery, time intervals when the patients first need to receive the drug were measured.
The VAS scores of the patients were lower in the side treated with DT than that in the paracetamol treated side. There was no significant difference between the groups in terms of mouth-opening limitation. MRI recordings revealed that swelling was lower in the side treated with paracetamol than DT treated side.
Administration of the drugs before surgery contributed to the postoperative patient comfort. The analgesic activity of 12.5 mg dose of DT was similar to, even better than, the analgesic activity of 500 mg dose of paracetamol; however, DT had insufficient anti-inflammatory efficacy.
本研究旨在调查右酮洛芬氨丁三醇(DT)和对乙酰氨基酚对接受阻生第三磨牙手术患者深部急性躯体疼痛和炎症的镇痛及抗炎作用。本研究旨在展示在低药物负担情况下我们能够获得的益处。
通过视觉模拟评分法(VAS)、磁共振成像(MRI)和开口度测量,评估术前预防性给药的药物对疼痛、开口受限和肿胀的影响。手术后,测量患者首次需要用药的时间间隔。
DT治疗侧患者的VAS评分低于对乙酰氨基酚治疗侧。两组在开口受限方面无显著差异。MRI记录显示,对乙酰氨基酚治疗侧的肿胀低于DT治疗侧。
术前给药有助于提高术后患者的舒适度。12.5mg剂量的DT的镇痛活性与500mg剂量的对乙酰氨基酚相似,甚至更好;然而,DT的抗炎疗效不足。